Frontlight ResearchEarly access
Trial site
National Health Insurance Service - Ilsan Hospital
- 1running trial
- 3closed trials
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- IgA nephropathy1 trial
- Osteoarthritis1 trial
- Peripheral artery disease1 trial
- Type 1 diabetes1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed2 trials
- Active, not recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- CSL Behring1 trial
- G2e Co., Ltd1 trial
- L&C Bio1 trial
- Novartis Pharmaceuticals1 trial
Running trials
Closed trials
Completed
Recruiting
Completed
Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)
Site data: ClinicalTrials.govUpdated 13 Nov 2026